Deleted Tweets From Scott Gottlieb, R-D.C.

RT @SGottliebFDA: I know the shutdown, coming during holidays, is especially hard on the people of FDA. After a busy, successful, but… https://t.co/w9xHwifbHA

I’m going to be tweeting out photos from our field force this weekend; acknowledging the work of our dedicated #FDA staff that continues through the shutdown. And the colleagues who are carrying out these critical public health functions - on the front lines, protecting Americans

RT @bvantine1: @SGottliebFDA @US_FDA Thank you, I just got compassionate use of a drug for a patient and the FDA was amazing rapid in its response.

Huge thanks to all who are working this holiday to protect us; whether at #FDA, our service members, or emergency responders. Happy holidays to you and your families, we recognize your commitment and sacrifice. A special shout out to my FDA colleagues working through the shutdown https://t.co/W4CbwHlie8

RT @DrMiguelPerales: Thanks @SGottliebFDA for highlighting dedicated @US_FDA staff who ensure public safety for all of us - they deserve pa… QT @SGottliebFDA: I want to share some pictures from the front lines of #FDA colleagues hard at work through the shutdown. I'm proud… https://t.co/1hVNx5KDd4)

Every American deserves access to quality healthcare and the protections of public health. This Christmas I want to thank the men and women of #FDA who work each day to help provide these opportunities. Each member of the #FDA team is integral to the agency’s critical mission.

Pictures from FDA today: Many thanks to all my #FDA colleagues who are working to implement an orderly shutdown. I’ll be posting information later today on how the agency will be handling medical product applications. https://t.co/tc2FhAzIfv

Scenes from FDA today: #FDA Deputy Commissioner Anna Abram (center), Associate Commissioner Keagan Lenihan (left) and Chief Operating Officer Jim Sigg (far right) helping implement plans for continuing operations of critical public health functions through the shutdown. https://t.co/1tZY4ePT8G

#FDA scientists at work today prepping ongoing experiments for the shutdown; here feeding a cell culture to help tide it over. https://t.co/E2ES5BGfSw

RT @SGottliebFDA: THREAD: During this partial government shutdown, the #FDA is able to continue activities involving the safety of hu… https://t.co/aYWYmXMLCZ

THREAD: During this partial government shutdown, the #FDA is able to continue activities involving the safety of human life. As such, we continue important work related to the importation of products we regulate....

This includes: Entry review of all products to determine the potential risk to health (for example, to determine whether the product poses an imminent threat to health/life). It also encompasses examination - including sampling - of products that may pose a high risk to health...

Also included: Detention of product, including products subject to detention without physical examination, if product may pose a high risk to health. And Mail Facility operations; examination of packages to detect counterfeit and other products that may pose high risk to health.

THREAD: I'm deeply concerned that kids use of e-cigs is accelerating, and we could see sharp rises in middle and high school use of e-cigs in 2019, on top of the 78% increase in teen use 2018; even despite interventions we’ve already taken and more steps we’ll soon implement. 1/5

RT @BillRehkopf: My wife is one of those pictured. Was supposed to be on leave, but getting it done for the cause. Respect to all in simila… QT @SGottliebFDA: Many thanks to all the #FDA colleagues who manned critical posts today and a special thanks to our more than 1,000… https://t.co/bLze5yCMif)

Many thanks to all the #FDA colleagues who manned critical posts today and a special thanks to our more than 1,000 Conmisioned Corps officials at FDA who will continue to serve through the shutdown to secure FDA’s vital public health functions. https://t.co/pCDjPL5AWj

RT @CDCgov: #Parents: We know you protect your little ones from the cold in winter. This holiday season, you can protect them… https://t.co/9Kj0RWdatZ

I’m writing CEOs of e-cig manufacturers asking them to meet to discuss commitments they made last month, and why some are changing course. This is an urgent matter. We're at a critical juncture. The opportunity for harm reduction for adults could be lost for a generation. 3/5

Met today with #FDA's data systems management and cybersecurity teams to get briefed on our security measures and additional steps that we're taking to keep critical systems running and safeguard information during the shutdown. https://t.co/6Yx2KDfUJP

The #FDA continues to conduct our own inquiries and/or investigations of e-cig makers related to marketing activities and other product-related issues. I'll be reaching out to CEOs to schedule new meetings. Manufacturers and management are accountable for the youth epidemic. 5/5

The vaping community that supports harm reduction for adults should also focus more of their efforts on select manufacturers that are primarily responsible for the youth epidemic if, like #FDA, they seek to preserve these opportunities as a way to transition adult smokers. 4/5

We’ll apply the new actions we announced to confront these trends. But data I’ve seen raises alarm. There’s no reason manufacturers must wait for #FDA to more forcefully address the epidemic. Yet some already appear to back away from commitments made to FDA and the public. 2/5

SHUTDOWN UPDATE: Our inspection and interdiction work continues at the International Mail Facilities: At Miami airport’s International Mail Facility, #FDA’s Isis Bermudez helps protect U.S. borders from packages potentially containing counterfeit and contaminated drugs. https://t.co/gOOZHY8YtK

#FDA’S Yessica Lopez-Villafane also working at Miami’s International Mail Facility during this lapse in funding to inspect suspicious parcels being sent to the U.S. border. https://t.co/iE53YhVzR6

Many asked if #FDA can accept new medical product applications during the shutdown. The #FDA can't collect FY 2019 user fee payments during the shutdown, which means we can't accept new applications for products under user fee programs: PDUFA, GDUFA, BsUFA, MDUFA, ADUFA, AGDUFA.

#FDA retains limited carryover balances for 21st Century Cures and opioids funding. These balances will only be spent on activities for which the funds are authorized. FDA carryover user-fee funds also allow the agency to continue work on existing user-fee related applications.

RT @SGottliebFDA: #FDA’S Yessica Lopez-Villafane also working at Miami’s International Mail Facility during this lapse in funding to inspect suspicious parcels being sent to the U.S. border. https://t.co/iE53YhVzR6

Images from some of #FDA's critical work that continues: Here FDA on duty at Chicago O’Hare Airport’s International Mail Facility. Consumer Safety Officers John Seale and Yuriy Solovyov support our mission examining potentially violative products attempting to enter US commerce. https://t.co/61cF5KU88u

1/2 We've received lots of questions regarding generic drugs during the shutdown. New GDUFA submissions that'll be processed with carryover user fees include: CBE and prior approval supplements, amendments, annual reports, applications for PET drugs, and general correspondence...

2/2 #FDA will also be accepting Drug Master Files, including Type II Active Pharmaceutical Ingredient (API) DMFs, to be referenced in generic drug applications. However, we can't conduct initial completeness assessments on Type II API DMFs if the fee hasn’t been already paid.

Met with the team at #FDA that’s supporting the communication and technology needs of our employees during the shutdown and helping us maintain critical public health functions. https://t.co/tTsPmNwByp

RT @pewhealth: “Physicians treating serious infections must have up-to-date [information] so they can select the best treatment for their patient’s infection.” - @SGottliebFDA What @US_FDA is doing to ensure this: https://t.co/3ehP1D58IR

RT @califf001: Commissioned core--huge national asset that i knew little about till my time at FDA. They are always on call to help where needed. Talk to young people about volunteering. Great to see recognition by Commish. @dukeforge https://t.co/mHnnCXPbcY

The #FDA’s Operations Office: Mission control today as we operate through the shutdown. https://t.co/HiKswPzOKx

RT @HHSGov: You don't have to wait for new years to #QuitSmoking. Sign up for @SmokefreeUs' daily text message program to get t… https://t.co/mSSzovbR6z

RT @DrMcCance_Katz: The holiday season affords us extra occasions to check in on loved ones. If you have a loved one who is struggling… https://t.co/sJ0dzwkCVM

2/2: For our Center for Drug Evaluation and Research this also includes pausing all OTC monograph drug activities. Only emergency work related to these products will continue.

3/4 The 30-day review clock for any pending, non-emergency IND for a medical product that is not covered by a user fee program will be suspended during the lapse period. The clock will resume when the lapse period is over.

THREAD: We have questions re: drug review work that’s not user fee funded and won’t continue during shutdown. CBER will pause non-emergency work on whole blood, blood components for transfusion, allergenic extracts and HCT/Ps regulated solely under sec. 361 of the PHSA. 1/4

4/4: However, new emergency INDs and IND amendments that relate to the safety of individuals who are participating in clinical trials will continue to be reviewed during the government shutdown, even for products that are not covered by a user fee program.

RT @FrankYiannasFDA: During the partial shutdown, to the extent permitted by the law, critical @US_FDA public health activities continue… https://t.co/v8ihd4PWW3

For timely updates on #FDA’s food safety related activities during the government shutdown follow our Deputy Commissioner @FrankYiannasFDA

RT @FDASpox: FDA is lucky to have the support of our dedicated Commission Corp Officers during this partial lapse in funding. To… https://t.co/osUcVKdu4W

To the many #FDA colleagues who were at their posts this week operating critical functions through the shutdown, and many more who are critical to our work but on furlough, I hope you have a peaceful New Years with family. I’m grateful for your dedication to our shared mission. https://t.co/xdUQNEuxaT

RT @SGottliebFDA: I want my #FDA colleagues to know I recognize the personal hardship this shutdown imposes on them, the uncertainty,… https://t.co/tLps8kgA6L

I want my #FDA colleagues to know I recognize the personal hardship this shutdown imposes on them, the uncertainty, and the impact on work that’s meaningful to us and to the American people. I stand by you and will do whatever I can to restore critical functions and support you. https://t.co/iaNGCKvWcV

RT @IDSAInfo: If you haven’t gotten a flu shot yet, there’s still time! @CDCgov reports that flu season has passed “regular” acti… https://t.co/u5Pbl1R4AG

RT @NCIDirector: In FY2019, we plan to increase @theNCI support for research project grants, stay true to the vision of… https://t.co/iL9DiUDWEH

RT @NCIResearchCtr: Dr. Rosenberg of the @NCI_CCR_SB and his daughter talk about their Christmas Eve tradition of working in the hospit… https://t.co/23mYmoeNFD

If your New Year's Resolution is to #QuitSmoking, @SmokefreeGov's QuitGuide app may be able to help: https://t.co/GWQPHY1zal https://t.co/zIjxJjy6Dr

RT @SGottliebFDA: I know the shutdown, coming during holidays, is especially hard on the people of FDA. After a busy, successful, but… https://t.co/w9xHwifbHA

I’m going to be tweeting out photos from our field force this weekend; acknowledging the work of our dedicated #FDA staff that continues through the shutdown. And the colleagues who are carrying out these critical public health functions - on the front lines, protecting Americans

RT @bvantine1: @SGottliebFDA @US_FDA Thank you, I just got compassionate use of a drug for a patient and the FDA was amazing rapid in its response.

Huge thanks to all who are working this holiday to protect us; whether at #FDA, our service members, or emergency responders. Happy holidays to you and your families, we recognize your commitment and sacrifice. A special shout out to my FDA colleagues working through the shutdown https://t.co/W4CbwHlie8

RT @DrMiguelPerales: Thanks @SGottliebFDA for highlighting dedicated @US_FDA staff who ensure public safety for all of us - they deserve pa… QT @SGottliebFDA: I want to share some pictures from the front lines of #FDA colleagues hard at work through the shutdown. I'm proud… https://t.co/1hVNx5KDd4)

Every American deserves access to quality healthcare and the protections of public health. This Christmas I want to thank the men and women of #FDA who work each day to help provide these opportunities. Each member of the #FDA team is integral to the agency’s critical mission.

Pictures from FDA today: Many thanks to all my #FDA colleagues who are working to implement an orderly shutdown. I’ll be posting information later today on how the agency will be handling medical product applications. https://t.co/tc2FhAzIfv

Scenes from FDA today: #FDA Deputy Commissioner Anna Abram (center), Associate Commissioner Keagan Lenihan (left) and Chief Operating Officer Jim Sigg (far right) helping implement plans for continuing operations of critical public health functions through the shutdown. https://t.co/1tZY4ePT8G

#FDA scientists at work today prepping ongoing experiments for the shutdown; here feeding a cell culture to help tide it over. https://t.co/E2ES5BGfSw

RT @SGottliebFDA: THREAD: During this partial government shutdown, the #FDA is able to continue activities involving the safety of hu… https://t.co/aYWYmXMLCZ

THREAD: During this partial government shutdown, the #FDA is able to continue activities involving the safety of human life. As such, we continue important work related to the importation of products we regulate....

This includes: Entry review of all products to determine the potential risk to health (for example, to determine whether the product poses an imminent threat to health/life). It also encompasses examination - including sampling - of products that may pose a high risk to health...

Also included: Detention of product, including products subject to detention without physical examination, if product may pose a high risk to health. And Mail Facility operations; examination of packages to detect counterfeit and other products that may pose high risk to health.

THREAD: I'm deeply concerned that kids use of e-cigs is accelerating, and we could see sharp rises in middle and high school use of e-cigs in 2019, on top of the 78% increase in teen use 2018; even despite interventions we’ve already taken and more steps we’ll soon implement. 1/5

RT @BillRehkopf: My wife is one of those pictured. Was supposed to be on leave, but getting it done for the cause. Respect to all in simila… QT @SGottliebFDA: Many thanks to all the #FDA colleagues who manned critical posts today and a special thanks to our more than 1,000… https://t.co/bLze5yCMif)

Many thanks to all the #FDA colleagues who manned critical posts today and a special thanks to our more than 1,000 Conmisioned Corps officials at FDA who will continue to serve through the shutdown to secure FDA’s vital public health functions. https://t.co/pCDjPL5AWj

RT @CDCgov: #Parents: We know you protect your little ones from the cold in winter. This holiday season, you can protect them… https://t.co/9Kj0RWdatZ

I’m writing CEOs of e-cig manufacturers asking them to meet to discuss commitments they made last month, and why some are changing course. This is an urgent matter. We're at a critical juncture. The opportunity for harm reduction for adults could be lost for a generation. 3/5

Met today with #FDA's data systems management and cybersecurity teams to get briefed on our security measures and additional steps that we're taking to keep critical systems running and safeguard information during the shutdown. https://t.co/6Yx2KDfUJP

The #FDA continues to conduct our own inquiries and/or investigations of e-cig makers related to marketing activities and other product-related issues. I'll be reaching out to CEOs to schedule new meetings. Manufacturers and management are accountable for the youth epidemic. 5/5

The vaping community that supports harm reduction for adults should also focus more of their efforts on select manufacturers that are primarily responsible for the youth epidemic if, like #FDA, they seek to preserve these opportunities as a way to transition adult smokers. 4/5

We’ll apply the new actions we announced to confront these trends. But data I’ve seen raises alarm. There’s no reason manufacturers must wait for #FDA to more forcefully address the epidemic. Yet some already appear to back away from commitments made to FDA and the public. 2/5

SHUTDOWN UPDATE: Our inspection and interdiction work continues at the International Mail Facilities: At Miami airport’s International Mail Facility, #FDA’s Isis Bermudez helps protect U.S. borders from packages potentially containing counterfeit and contaminated drugs. https://t.co/gOOZHY8YtK

#FDA’S Yessica Lopez-Villafane also working at Miami’s International Mail Facility during this lapse in funding to inspect suspicious parcels being sent to the U.S. border. https://t.co/iE53YhVzR6

Many asked if #FDA can accept new medical product applications during the shutdown. The #FDA can't collect FY 2019 user fee payments during the shutdown, which means we can't accept new applications for products under user fee programs: PDUFA, GDUFA, BsUFA, MDUFA, ADUFA, AGDUFA.

#FDA retains limited carryover balances for 21st Century Cures and opioids funding. These balances will only be spent on activities for which the funds are authorized. FDA carryover user-fee funds also allow the agency to continue work on existing user-fee related applications.

RT @SGottliebFDA: #FDA’S Yessica Lopez-Villafane also working at Miami’s International Mail Facility during this lapse in funding to inspect suspicious parcels being sent to the U.S. border. https://t.co/iE53YhVzR6

Images from some of #FDA's critical work that continues: Here FDA on duty at Chicago O’Hare Airport’s International Mail Facility. Consumer Safety Officers John Seale and Yuriy Solovyov support our mission examining potentially violative products attempting to enter US commerce. https://t.co/61cF5KU88u

1/2 We've received lots of questions regarding generic drugs during the shutdown. New GDUFA submissions that'll be processed with carryover user fees include: CBE and prior approval supplements, amendments, annual reports, applications for PET drugs, and general correspondence...

2/2 #FDA will also be accepting Drug Master Files, including Type II Active Pharmaceutical Ingredient (API) DMFs, to be referenced in generic drug applications. However, we can't conduct initial completeness assessments on Type II API DMFs if the fee hasn’t been already paid.

Met with the team at #FDA that’s supporting the communication and technology needs of our employees during the shutdown and helping us maintain critical public health functions. https://t.co/tTsPmNwByp

RT @pewhealth: “Physicians treating serious infections must have up-to-date [information] so they can select the best treatment for their patient’s infection.” - @SGottliebFDA What @US_FDA is doing to ensure this: https://t.co/3ehP1D58IR

RT @califf001: Commissioned core--huge national asset that i knew little about till my time at FDA. They are always on call to help where needed. Talk to young people about volunteering. Great to see recognition by Commish. @dukeforge https://t.co/mHnnCXPbcY

The #FDA’s Operations Office: Mission control today as we operate through the shutdown. https://t.co/HiKswPzOKx

RT @HHSGov: You don't have to wait for new years to #QuitSmoking. Sign up for @SmokefreeUs' daily text message program to get t… https://t.co/mSSzovbR6z

RT @DrMcCance_Katz: The holiday season affords us extra occasions to check in on loved ones. If you have a loved one who is struggling… https://t.co/sJ0dzwkCVM

2/2: For our Center for Drug Evaluation and Research this also includes pausing all OTC monograph drug activities. Only emergency work related to these products will continue.

3/4 The 30-day review clock for any pending, non-emergency IND for a medical product that is not covered by a user fee program will be suspended during the lapse period. The clock will resume when the lapse period is over.

THREAD: We have questions re: drug review work that’s not user fee funded and won’t continue during shutdown. CBER will pause non-emergency work on whole blood, blood components for transfusion, allergenic extracts and HCT/Ps regulated solely under sec. 361 of the PHSA. 1/4

4/4: However, new emergency INDs and IND amendments that relate to the safety of individuals who are participating in clinical trials will continue to be reviewed during the government shutdown, even for products that are not covered by a user fee program.

RT @FrankYiannasFDA: During the partial shutdown, to the extent permitted by the law, critical @US_FDA public health activities continue… https://t.co/v8ihd4PWW3

For timely updates on #FDA’s food safety related activities during the government shutdown follow our Deputy Commissioner @FrankYiannasFDA

RT @FDASpox: FDA is lucky to have the support of our dedicated Commission Corp Officers during this partial lapse in funding. To… https://t.co/osUcVKdu4W

To the many #FDA colleagues who were at their posts this week operating critical functions through the shutdown, and many more who are critical to our work but on furlough, I hope you have a peaceful New Years with family. I’m grateful for your dedication to our shared mission. https://t.co/xdUQNEuxaT

RT @SGottliebFDA: I want my #FDA colleagues to know I recognize the personal hardship this shutdown imposes on them, the uncertainty,… https://t.co/tLps8kgA6L

I want my #FDA colleagues to know I recognize the personal hardship this shutdown imposes on them, the uncertainty, and the impact on work that’s meaningful to us and to the American people. I stand by you and will do whatever I can to restore critical functions and support you. https://t.co/iaNGCKvWcV

RT @IDSAInfo: If you haven’t gotten a flu shot yet, there’s still time! @CDCgov reports that flu season has passed “regular” acti… https://t.co/u5Pbl1R4AG

RT @NCIDirector: In FY2019, we plan to increase @theNCI support for research project grants, stay true to the vision of… https://t.co/iL9DiUDWEH

RT @NCIResearchCtr: Dr. Rosenberg of the @NCI_CCR_SB and his daughter talk about their Christmas Eve tradition of working in the hospit… https://t.co/23mYmoeNFD

If your New Year's Resolution is to #QuitSmoking, @SmokefreeGov's QuitGuide app may be able to help: https://t.co/GWQPHY1zal https://t.co/zIjxJjy6Dr